MOTS-C: FDA status and clinic comparison questions

What Is MOTS-C?

MOTS-C is not presented here as an FDA-approved treatment. Regulatory and compounding status can change; check current FDA information and do not infer availability or legality from a clinic listing.

Use the official sources below for the current product label, approval status, compounding information, and published research.

Questions to ask about MOTS-C

• What exact product, dose form, and intended use is being discussed?
• Is that product FDA-approved for this indication, compounded, or investigational?
• What evidence applies to people like me, and what uncertainty remains?
• What alternatives, contraindications, adverse effects, and monitoring should be discussed?

What to Expect at a Consultation

Ask the clinician to identify the exact product and intended use, explain FDA approval or compounding status, discuss the evidence and its limits, review alternatives and risks, describe monitoring and follow-up, name the dispensing pharmacy, and provide an itemised total cost. Requirements differ by person and jurisdiction.

Sources & References

Start with the official sources below. This directory summary is not a substitute for current FDA labeling, regulatory notices, or individual medical advice.

• FDA Drugs@FDA database - approval status and approved labeling for FDA-approved medications.
• FDA Human Drug Compounding - 503A/503B compounding rules and current restrictions.
• FDA guidance on unapproved & compounded drugs - context for peptides without standalone FDA approval.
• PubMed: MOTS-C research - peer-reviewed studies cited for the clinical claims above.